BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12791828)

  • 41. Increased uptake of [¹²³I]meta-iodobenzylguanidine, [¹⁸F]fluorodopamine, and [³H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors.
    Martiniova L; Perera SM; Brouwers FM; Alesci S; Abu-Asab M; Marvelle AF; Kiesewetter DO; Thomasson D; Morris JC; Kvetnansky R; Tischler AS; Reynolds JC; Fojo AT; Pacak K
    Endocr Relat Cancer; 2011 Feb; 18(1):143-57. PubMed ID: 21098082
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Noradrenaline transporter gene transfer for radiation cell kill by 131I meta-iodobenzylguanidine.
    Boyd M; Cunningham SH; Brown MM; Mairs RJ; Wheldon TE
    Gene Ther; 1999 Jun; 6(6):1147-52. PubMed ID: 10455418
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of monoamine transporters in neuroblastoma cell lines: correlations to meta-iodobenzylguanidine (MIBG) uptake and tyrosine hydroxylase gene expression.
    Lode HN; Bruchelt G; Seitz G; Gebhardt S; Gekeler V; Niethammer D; Beck J
    Eur J Cancer; 1995; 31A(4):586-90. PubMed ID: 7576974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of poly(ADP-Ribose) polymerase enhances the toxicity of 131I-metaiodobenzylguanidine/topotecan combination therapy to cells and xenografts that express the noradrenaline transporter.
    McCluskey AG; Mairs RJ; Tesson M; Pimlott SL; Babich JW; Gaze MN; Champion S; Boyd M
    J Nucl Med; 2012 Jul; 53(7):1146-54. PubMed ID: 22689924
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Iodide uptake in human anaplastic thyroid carcinoma cells after transfer of the human thyroid peroxidase gene.
    Haberkorn U; Altmann A; Jiang S; Morr I; Mahmut M; Eisenhut M
    Eur J Nucl Med; 2001 May; 28(5):633-8. PubMed ID: 11383870
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression in UVW glioma cells of the noradrenaline transporter gene, driven by the telomerase RNA promoter, induces active uptake of [131I]MIBG and clonogenic cell kill.
    Boyd M; Mairs RJ; Mairs SC; Wilson L; Livingstone A; Cunningham SH; Brown MM; Quigg M; Keith WN
    Oncogene; 2001 Nov; 20(53):7804-8. PubMed ID: 11753659
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumors.
    Carlin S; Mairs RJ; McCluskey AG; Tweddle DA; Sprigg A; Estlin C; Board J; George RE; Ellershaw C; Pearson AD; Lunec J; Montaldo PG; Ponzoni M; van Eck-Smit BL; Hoefnagel CA; van den Brug MD; Tytgat GA; Caron HN
    Clin Cancer Res; 2003 Aug; 9(9):3338-44. PubMed ID: 12960120
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [(131)I] and [(125)I] metaiodobenzylguanidine therapy in macroscopic and microscopic tumors: a comparative study in SK-N-SH human neuroblastoma and PC12 rat pheochromocytoma xenografts.
    Rutgers M; Buitenhuis CK; van der Valk MA; Hoefnagel CA; Voûte PA; Smets LA
    Int J Cancer; 2000 Dec; 90(6):312-25. PubMed ID: 11180134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characteristics and regulation of 123I-MIBG transport in cultured pulmonary endothelial cells.
    Lee KH; Ko BH; Paik JY; Jung KH; Bae JS; Choi JY; Choe YS; Kim BT
    J Nucl Med; 2006 Mar; 47(3):437-42. PubMed ID: 16513613
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A gene therapy approach to enhance the targeted radiotherapy of neuroblastoma.
    Cunningham S; Boyd M; Brown MM; Carlin S; McCluskey A; Livingstone A; Mairs RJ; Wheldon TE
    Med Pediatr Oncol; 2000 Dec; 35(6):708-11. PubMed ID: 11107152
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiation quality-dependent bystander effects elicited by targeted radionuclides.
    Boyd M; Sorensen A; McCluskey AG; Mairs RJ
    J Pharm Pharmacol; 2008 Aug; 60(8):951-8. PubMed ID: 18644188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extragranular storage of the neuron blocking agent meta-iodobenzylguanidine (MIBG) in human neuroblastoma cells.
    Smets LA; Janssen M; Metwally E; Loesberg C
    Biochem Pharmacol; 1990 Jun; 39(12):1959-64. PubMed ID: 2353937
    [TBL] [Abstract][Full Text] [Related]  

  • 53. No-carrier-added iodine-131-FIBG: evaluation of an MIBG analog.
    Vaidyanathan G; Zhao XG; Strickland DK; Zalutsky MR
    J Nucl Med; 1997 Feb; 38(2):330-4. PubMed ID: 9025764
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional characterization of the splicing variants of human norepinephrine transporter.
    Kitayama S; Morita K; Dohi T
    Neurosci Lett; 2001 Oct; 312(2):108-12. PubMed ID: 11595346
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sympathomimetic effects of MIBG: comparison with tyramine.
    Graefe KH; Bossle F; Wölfel R; Burger A; Souladaki M; Bier D; Dutschka K; Farahati J; Bönisch H
    J Nucl Med; 1999 Aug; 40(8):1342-51. PubMed ID: 10450687
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of high-specific-activity ultratrace 123/131I-MIBG and carrier-added 123/131I-MIBG on efficacy, pharmacokinetics, and tissue distribution.
    Barrett JA; Joyal JL; Hillier SM; Maresca KP; Femia FJ; Kronauge JF; Boyd M; Mairs RJ; Babich JW
    Cancer Biother Radiopharm; 2010 Jun; 25(3):299-308. PubMed ID: 20578835
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of transport function and desipramine binding at the human noradrenaline transporter by N-ethylmaleimide and protection by substrate analogs.
    Foley KF; Cozzi NV
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):457-61. PubMed ID: 12070759
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alterations of myocardial sympathetic innervation in response to hypoxia.
    Scherrer-Crosbie M; Mardon K; Cayla J; Syrota A; Merlet P
    J Nucl Med; 1997 Jun; 38(6):954-7. PubMed ID: 9189149
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial.
    Matthay KK; Weiss B; Villablanca JG; Maris JM; Yanik GA; Dubois SG; Stubbs J; Groshen S; Tsao-Wei D; Hawkins R; Jackson H; Goodarzian F; Daldrup-Link H; Panigrahy A; Towbin A; Shimada H; Barrett J; Lafrance N; Babich J
    J Nucl Med; 2012 Jul; 53(7):1155-63. PubMed ID: 22700000
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A transfectant mosaic xenograft model for evaluation of targeted radiotherapy in combination with gene therapy in vivo.
    Mairs RJ; Ross SC; McCluskey AG; Boyd M
    J Nucl Med; 2007 Sep; 48(9):1519-26. PubMed ID: 17704246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.